One out of every seven women will develop breast cancer in her lifetime. It is the second most common form of cancer in women after skin cancer and the second most deadly cancer in women after lung cancer. All women are at risk, but women over 40 and those with a family history of breast cancer have an even greater chance of developing the disease.
The Sanofi US Breast Care Program at The Steeplechase Cancer Center is dedicated to breast cancer prevention and early detection, giving women the best chance for successful treatment and potential cure.
The program, located on the third floor of the cancer center, offers comprehensive, personalized breast health services from routine screenings to complex diagnostic procedures and treatment evaluations. From warm, terrycloth robes to private waiting areas, the Breast Care Program is specially designed to ensure comfort and privacy for our patients.
The program's expert staff has extensive experience in the diagnosis and treatment of breast cancer, performing more screenings, diagnostic mammograms and breast biopsies than most other breast care centers in the state. The program has been designated a Breast Imaging Center of Excellence by the American College of Radiology and it meets the Food and Drug Administration's strict standards. The Breast Care Program is also accredited by the National Accreditation Program for Breast Centers.
For more information or to schedule an appointment, call 908-704-3740. To make it even easier for women to get their annual screening mammograms, the Sanofi US Breast Care Program now accepts self-referrals.
Free mammograms are available for women who are living on a limited income or who are uninsured or underinsured. Funding is provided through a grant from the New Jersey Cancer Education and Early Detection Program. For more information about eligibility requirements, call Women's Health & Counseling Center, the Somerset County grant administrator, at 908-526-2335, ext. 19.
Breast cancer treatments, such as chemotherapy and hormonal therapy with aromatase inhibitors, can impact your bone health. Before you start your treatment, your doctor may recommend a Dual-Energy X-ray Absorptiometry (DXA) scan for a baseline assessment of your bone density. This scan may be repeated after your treatment to determine if you have had any bone loss. It is also recommended that women over age 65 have a bone density scan to screen for osteoporosis.
The Sanofi US Breast Care Program at the Steeplechase Cancer Center at Robert Wood Johnson University Hospital Somerset offers the latest DXA scanning technology. The Prodigy system from GE provides a comprehensive body composition analysis, including bone mineral density and lean and fat tissue mass. Measurements can be taken in one scan, without requiring repositioning. The Prodigy system provides the highest quality images while minimizing radiation exposure. The scan uses 96 percent less radiation than other systems.
Screening exams, such as bone density testing, are covered by Medicare and most major insurance plans.